Targeted alpha therapy: progress in radionuclide production, radiochemistry, and applications

BJB Nelson, JD Andersson, F Wuest - Pharmaceutics, 2020 - mdpi.com
This review outlines the accomplishments and potential developments of targeted alpha (α)
particle therapy (TAT). It discusses the therapeutic advantages of the short and highly …

Targeted radium alpha therapy in the era of nanomedicine: in vivo results

G Trencsényi, C Csikos, Z Képes - International Journal of Molecular …, 2024 - mdpi.com
Targeted alpha-particle therapy using radionuclides with alpha emission is a rapidly
developing area in modern cancer treatment. To selectively deliver alpha-emitting isotopes …

Alpha dose modeling in diffusing alpha‐emitters radiation therapy—Part I: single‐seed calculations in one and two dimensions

G Heger, A Roy, M Dumančić, L Arazi - Medical Physics, 2023 - Wiley Online Library
Abstract Background Diffusing alpha‐emitters Radiation Therapy (“DaRT”) is a new method,
presently in clinical trials, which allows treating solid tumors by alpha particles. DaRT relies …

[HTML][HTML] Initial safety and tumor control results from a “first-in-human” multicenter prospective trial evaluating a novel alpha-emitting radionuclide for the treatment of …

A Popovtzer, E Rosenfeld, A Mizrachi, SR Bellia… - International Journal of …, 2020 - Elsevier
Purpose Our purpose was to report the feasibility and safety of diffusing alpha-emitter
radiation therapy (DaRT), which entails the interstitial implantation of a novel alpha-emitting …

Alpha dose modeling in diffusing alpha‐emitters radiation therapy. Part II: Lattice studies

G Heger, M Dumančić, A Roy, L Arazi - Medical Physics, 2023 - Wiley Online Library
Background Diffusing alpha‐emitters radiation therapy (“DaRT”) is a new method, presently
in clinical trials, which allows treating solid tumors by alpha particles. DaRT relies on …

Combining alpha radiation-based brachytherapy with immunomodulators promotes complete tumor regression in mice via tumor-specific long-term immune response

V Domankevich, A Cohen, M Efrati, M Schmidt… - Cancer Immunology …, 2019 - Springer
Diffusing alpha-emitters radiation therapy (DaRT) is the only known method for treating solid
tumors with highly destructive alpha radiation. More importantly, as a monotherapy, DaRT …

Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts

Y Nishri, M Vatarescu, I Luz, L Epstein… - Frontiers in …, 2022 - frontiersin.org
Glioblastoma multiforme (GBM) is at present an incurable disease with a 5-year survival rate
of 5.5%, despite improvements in treatment modalities such as surgery, radiation therapy …

Clinical evidence of abscopal effect in cutaneous squamous cell carcinoma treated with diffusing alpha emitters radiation therapy: a case report

S Bellia, G Feliciani, M Duca, M Monti, V Turri… - Journal of …, 2019 - termedia.pl
Purpose The abscopal effect (AE) is a sporadic event of tumor regression following
radiotherapy treatment observed at distance from irradiated site. For the first time, the term …

Diffusing alpha-emitters radiation therapy: approximate modeling of the macroscopic alpha particle dose of a point source

L Arazi - Physics in Medicine & Biology, 2020 - iopscience.iop.org
Diffusing alpha-emitters radiation therapy ('DaRT') is a new cancer-treatment modality,
which enables treating solid tumors by alpha particles. The treatment utilizes implantable …

RIG-1-like receptor activation synergizes with intratumoral alpha radiation to induce pancreatic tumor rejection, triple-negative breast metastases clearance, and …

V Domankevich, M Efrati, M Schmidt, E Glikson… - Frontiers in …, 2020 - frontiersin.org
Diffusing alpha-emitting radiation therapy (DaRT) employs intratumoral Ra-224-coated
seeds that efficiently destroy solid tumors by slowly releasing alpha-emitting atoms inside …